PDT Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-57,915
| Closed | -$284K | – | 870 |
|
|
2022
Q3 | $284K | Sell |
57,915
-6,961
| -11% | -$35.8K | 0.04% | 611 |
|
|
2022
Q2 | $269K | Buy |
64,876
+13,292
| +26% | +$57.5K | 0.02% | 764 |
|
|
2022
Q1 | $300K | Buy |
51,584
+8,253
| +19% | +$49.1K | 0.03% | 722 |
|
|
2021
Q4 | $325K | Sell |
43,331
-167,754
| -79% | -$1.46M | 0.02% | 650 |
|
|
2021
Q3 | $1.9M | Sell |
211,085
-37,388
| -15% | -$370K | 0.14% | 250 |
|
|
2021
Q2 | $2.97M | Buy |
248,473
+17,894
| +8% | +$203K | 0.2% | 221 |
|
|
2021
Q1 | $2.89M | Sell |
230,579
-1,653
| -0.7% | -$22.3K | 0.21% | 205 |
|
|
2020
Q4 | $3.62M | Sell |
232,232
-87,694
| -27% | -$1.03M | 0.24% | 183 |
|
|
2020
Q3 | $3.02M | Buy |
319,926
+155,407
| +94% | +$1.68M | 0.2% | 171 |
|
|
2020
Q2 | $1.47M | Buy |
+164,519
| New | +$1.53M | 0.1% | 234 |
|
|
2020
Q1 | – | Sell |
-176,203
| Closed | -$1.48M | – | 837 |
|
|
2019
Q4 | $1.48M | Sell |
176,203
-54,425
| -24% | -$500K | 0.09% | 224 |
|
|
2019
Q3 | $2.09M | Buy |
230,628
+267
| +0.1% | +$3K | 0.12% | 200 |
|
|
2019
Q2 | $2.48M | Buy |
+230,361
| New | +$2.45M | 0.15% | 165 |
|
|
2018
Q4 | – | Sell |
-196,212
| Closed | -$3.33M | – | 508 |
|
|
2018
Q3 | $3.33M | Sell |
196,212
-98,794
| -33% | -$1.5M | 0.14% | 182 |
|
|
2018
Q2 | $4.19M | Sell |
295,006
-159,430
| -35% | -$2.65M | 0.16% | 171 |
|
|
2018
Q1 | $8.63M | Sell |
454,436
-17,213
| -4% | -$368K | 0.29% | 118 |
|
|
2017
Q4 | $7.74M | Buy |
+471,649
| New | +$7.02M | 0.22% | 148 |
|
|
2017
Q2 | – | Sell |
-107,000
| Closed | -$556K | – | 563 |
|
|
2017
Q1 | $556K | Buy |
107,000
+21,600
| +25% | +$86.6K | 0.03% | 367 |
|
|
2016
Q4 | $260K | Sell |
85,400
-47,000
| -35% | -$171K | 0.02% | 447 |
|
|
2016
Q3 | $613K | Buy |
132,400
+300
| +0.2% | +$1.53K | 0.04% | 353 |
|
|
2016
Q2 | $765K | Buy |
132,100
+19,500
| +17% | +$124K | 0.06% | 288 |
|
|
2016
Q1 | $681K | Buy |
+112,600
| New | +$676K | 0.04% | 367 |
|
|
2015
Q4 | – | Sell |
-79,216
| Closed | -$447K | – | 869 |
|
|
2015
Q3 | $447K | Buy |
79,216
+50,307
| +174% | +$415K | 0.01% | 935 |
|
|
2015
Q2 | $321K | Buy |
+28,909
| New | +$373K | 0.01% | 1114 |
|
|
2014
Q4 | – | Sell |
-33,294
| Closed | -$359K | – | 1030 |
|
|
2014
Q3 | $359K | Buy |
+33,294
| New | +$435K | 0.01% | 1054 |
|
|
2013
Q3 | – | Sell |
-89,647
| Closed | -$700K | – | 1690 |
|
|
2013
Q2 | $700K | Buy |
+89,647
| New | +$782K | 0.02% | 940 |
|
Other funds holding SGMO
WA
CS
N
RCMU
APM
PDT Partners's SGMO Position: Q4 2022 in Review
PDT Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 57,915 shares — an estimated $284K sold.
PDT Partners first reported a position in SGMO in Q2 2013 and held it in 26 quarters. The position peaked at $8.63M in Q1 2018. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.
- PDT Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
- PDT Partners sold 57,915 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $284K.
- PDT Partners first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 26 quarters.
- PDT Partners's SANGAMO THERAPEUTICS INC position peaked at $8.63M in Q1 2018.
- 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.
Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.